462 related articles for article (PubMed ID: 19571724)
1. Stavudine in antiretroviral therapy: is this the end?
Brinkman K
AIDS; 2009 Aug; 23(13):1727-9. PubMed ID: 19571724
[No Abstract] [Full Text] [Related]
2. Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy.
Shah SS; Rodriguez T; McGowan JP
Clin Infect Dis; 2003 May; 36(10):e131-3. PubMed ID: 12746793
[TBL] [Abstract][Full Text] [Related]
3. The role of nucleoside reverse transcriptase inhibitors in the fat redistribution syndrome.
Nolan D; Mallal S
J HIV Ther; 2004 May; 9(2):34-40. PubMed ID: 15238874
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous toxicities of antiretroviral therapy for HIV: part I. Lipodystrophy syndrome, nucleoside reverse transcriptase inhibitors, and protease inhibitors.
Introcaso CE; Hines JM; Kovarik CL
J Am Acad Dermatol; 2010 Oct; 63(4):549-61; quiz 561-2. PubMed ID: 20846563
[TBL] [Abstract][Full Text] [Related]
5. Symptomatic hyperlactatemia in an HIV-positive patient: a case report and discussion.
Antoniou T; Weisdorf T; Gough K
CMAJ; 2003 Jan; 168(2):195-8. PubMed ID: 12538549
[TBL] [Abstract][Full Text] [Related]
6. The role of zidovudine in development of lipoatrophy.
Moyle GJ
AIDS Read; 2005 Nov; 15(11):591-4, 599-600, 603. PubMed ID: 16329181
[No Abstract] [Full Text] [Related]
7. Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy.
Nelson M; Azwa A; Sokwala A; Harania RS; Stebbing J
AIDS; 2008 Jul; 22(11):1374-6. PubMed ID: 18580619
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral therapy in HIV patients: aspects of metabolic complications and mitochondrial toxicity.
ter Hofstede HJ; Burger DM; Koopmans PP
Neth J Med; 2003 Dec; 61(12):393-403. PubMed ID: 15025414
[No Abstract] [Full Text] [Related]
9. What does the term "HIV-associated lipodystrophy" mean?
Marcason W
J Am Diet Assoc; 2009 Feb; 109(2):364. PubMed ID: 19167963
[No Abstract] [Full Text] [Related]
10. HIV-associated lipodystrophy syndrome: LioN-HAART cohort: (lipodystrophy in patients on nucleoside-based HAART). Highly active antiretroviral therapy.
Lauenroth-Mai E; Schlote F
J Acquir Immune Defic Syndr; 2002 Oct; 31(2):253-5. PubMed ID: 12394807
[No Abstract] [Full Text] [Related]
11. Replacing stavudine by abacavir reduces lactate levels and may improve lipoatrophy.
García-Benayas T; Blanco F; de la Cruz JJ; Soriano V; González-Lahoz J
AIDS; 2003 Apr; 17(6):921-4. PubMed ID: 12660543
[No Abstract] [Full Text] [Related]
12. Non-nucleoside-reverse-transcriptase-inhibitor-based HAART and osteoporosis in HIV-infected subjects.
Bongiovanni M; Fausto A; Cicconi P; Aliprandi A; Cornalba G; Bini T; Sardanelli F; D'Arminio Monforte A
J Antimicrob Chemother; 2006 Aug; 58(2):485-6. PubMed ID: 16751202
[No Abstract] [Full Text] [Related]
13. HAART-associated body habitus and metabolic changes, Part 1.
Liss M; Boyle BA
AIDS Read; 2000 Nov; 10(11):622, 629-31. PubMed ID: 11186180
[No Abstract] [Full Text] [Related]
14. High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda.
van Griensven J; De Naeyer L; Mushi T; Ubarijoro S; Gashumba D; Gazille C; Zachariah R
Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):793-8. PubMed ID: 17467756
[TBL] [Abstract][Full Text] [Related]
15. Nucleoside analogues and mitochondrial toxicity.
Fleischer R; Boxwell D; Sherman KE
Clin Infect Dis; 2004 Apr; 38(8):e79-80. PubMed ID: 15095236
[TBL] [Abstract][Full Text] [Related]
16. Lactic acidosis secondary to nucleoside analogue antiretroviral therapy.
Khouri S; Cushing H
AIDS Read; 2000 Oct; 10(10):602-6. PubMed ID: 11068807
[TBL] [Abstract][Full Text] [Related]
17. Stavudine-induced hyperlactatemia/lactic acidosis at a tertiary communicable diseases clinic in South Africa.
Hernández Pérez E; Dawood H
J Int Assoc Physicians AIDS Care (Chic); 2010; 9(2):109-12. PubMed ID: 20484736
[TBL] [Abstract][Full Text] [Related]
18. Stavudine-induced macrocytosis during therapy for human immunodeficiency virus infection.
Martin GJ; Blazes DL; Mayers DL; Spooner KM
Clin Infect Dis; 1999 Aug; 29(2):459-60. PubMed ID: 10476771
[No Abstract] [Full Text] [Related]
19. Update on mitochondrial toxicity of antiretrovirals and its link to lipodystrophy.
McComsey G
AIDS Rev; 2002; 4(3):140-7. PubMed ID: 12416448
[TBL] [Abstract][Full Text] [Related]
20. Beyond lipodystrophy: will toxicity issues ever outweigh the benefits of HAART?
Vella S; Palmisano L
J HIV Ther; 2003 May; 8(2):27-8. PubMed ID: 15587479
[No Abstract] [Full Text] [Related]
[Next] [New Search]
